Scientists have finally uncovered how bacteria naturally create multiple versions of powerful anti-cancer drugs, solving a mystery that has frustrated researchers for decades.

Anthropic has introduced Claude Science, a new AI workbench for scientists that integrates research tools, produces auditable artifacts, and connects to specialized life sciences models and workflows ...

UHPLC-MS/MS enabled phenolic fingerprinting of ten Algerian honeys, revealing 22 compounds with quinic acid, gallic acid, naringenin, and acacetin most abundant. Botanical origin and geography drove ...

A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...

NVIDIA Corporation (NASDAQ:NVDA) is extending its physical AI ambitions on two fronts simultaneously, pushing deeper into ...

CSIR-IICT scientists have used AI-driven structural bioinformatics to identify a promising repurposed drug candidate against poxviruses, including Mpox and Lumpy Skin Disease Virus.

NVIDIA Corporation (NASDAQ: NVDA) is one of the high growth stocks to buy right now. On June 23, NVIDIA introduced the ...

Cancer is one of the leading causes of mortality worldwide, and current therapies face significant limitations in terms of ...

NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life ...

Tiny robots built from biomolecules and nanoparticles have long promised a more precise way to deliver drugs, run chemical ...

Artificial intelligence played a prominent role at this week’s Bio International Convention in San Diego, the largest biotech ...

Modular nanorobot from University of Basel cut cancer cell viability to 16% by synthesizing drugs directly on cell surfaces ...